CD28 and acute lymphoblastic leukemia: They exhibited enhanced antitumour activity and prolonged survival in a mouse model of primary human pre-B cell ALL and were significantly more effective than T cells expressing CD19 CARs containing CD3 zeta alone or CD28/CD3 zeta 71.